ObsEva to Present at the H.C. Wainwright Global Life Sciences Conference
March 03, 2021 01:00 ET
|
ObsEva SA
Geneva, Switzerland and Boston, MA – March 3, 2021 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive...
ObsEva SA to Participate in Upcoming Investor Conferences
April 01, 2019 01:00 ET
|
ObsEva SA
Geneva, Switzerland and Boston, MA – April 1, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel...